MIRA INFORM REPORT

 

 

Report No. :

312531

Report Date :

01.06.2015

 

IDENTIFICATION DETAILS

 

Name :

YAGNA MEDICAL SCIENCE

 

 

Registered Office :

3rd Floor, Omkar – 1, Opposite Police Parade Ground, GPO Lane, Baroda – 390001, Gujarat

Tel. No.:

91-265-2418955

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Year of Establishment:

2008

 

 

Capital Investment / Paid-up Capital :

Rs. 4.512 Million

 

 

TIN No.:

Not Available

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

Partnership Concern with an Unlimited Liability of the Partners

 

 

Line of Business :

Trader of Pharma Products

 

 

No. of Employees :

6 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was established in the year 2008 as proprietary concern and engaged into trading business of pharma products. It is an established concern having a satisfactory track record.

 

Concern only undertakes local trading of pharma products and it does not any import and export activities.

 

As per the financial statement of 2014, concern reported marginal increased in its sales turnover and it has maintained profitability margins at 0.91%.

 

Rating also takes into account of decent experience of partners in pharma trading business and sound operational profile of the concern.

 

Trade relations are reported as fair. Payment terms are reported to be usually correct.

 

In view of aforesaid, the concern can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Jaydeep Trivedi

Designation :

Partner

Contact No.:

91-9824027555

Date :

23.04.2015

 

LOCATIONS

 

Registered Office :

3rd Floor, Omkar – 1, Opposite Police Parade Ground, GPO Lane, Baroda – 390001, Gujarat, India

Tel. No.:

91-265-2418955

Mobile No.:

91-9824027555 (Mr. Jaydeep)

E-Mail :

yagunamedical@yahoo.com

Area :

700 sq. ft.

Location :

Owned

 

 

PARTNERS

 

Name :

Mr. Jaydeep Trivedi

Designation :

Partner

 

 

Name :

Mrs. Dipti Trivedi

Designation :

Partner

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Pharma Products

 

 

Products :

Not Divulged

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Johnsons and Johnsons

Name of the Person :

Mr. Ritesh (Cleark)

Contact No.:

91-271-8300310

Since How Long Known :

10 Years

Maximum Limit Dealt :

Not Divulged

Experience :

Good

Remark:

They gave us positive response about subject company they are satisfied with their payment behavior market goodwill.

 

 

Customers :

Reference :

Bhailal  Amin General Hospital

Name of the Person :

Mr. Jayesh (Purchase Officer)

Contact No.:

91-9624261110

Since How Long Known :

15 Years

Maximum Limit Dealt :

Not Divulged

Experience :

Good

Remark:

They gave us positive response about subject company they are satisfied with their product quality and delivery behavior.

 

 

No. of Employees :

6 (Approximately)

 

 

Bankers :

Bank Name

Bank of Baroda

Branch

O.P Road Branch, Vadodara, Gujarat, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Dinesh Thakkar and Company

Chartered Accountants

Address :

Dandia Bazar, Vadodara, Gujarat, India

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Our Present Business Associates:

  • Johnson And Johnson Limited [Nephrology And Virology]

 

  • Roche Products India [Nephrology, Virology, Oncology]

 

  • Novartis India Limited [Kidney Transplant]

 

  • Genzyme Biotechnology Company

 

  • Genzyme Biotechnology Company

 

  • Sanofi Aventies

 

  • Abbot Laboratories

 

  • Panacea Biotec

 

  • Biocon Pharmacuaticals

 

  • Emcure Pharmacuaticals

 

  • Gennova Biopharmacuaticals

 

  • Claris Lifescience

 

  • Larenon

 

  • Wockhardt

 

  • Gamro

 

  • Fresinous Pump

 

  • Mindray

 

  • Philips

 

  • Air Liquid France

 

CAPITAL STRUCTURE

 

AS ON 31.03.2015

 

Capital Investment :

 

Owned :

Rs. 4.512 Million

Borrowed :

--

Total :

Rs. 4.512 Million

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

 

SOURCES OF FUNDS

 

31.03.2015

(PROVISIONAL)

31.03.2014

31.03.2013

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

4.512

2.407

3.204

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

4.512

2.407

3.204

LOAN FUNDS

 

 

 

1] Secured Loans

2.845

2.187

2.386

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

2.845

2.187

2.386

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

7.357

4.594

5.590

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

0.735

0.632

0.730

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.015

0.015

0.015

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

3.540
3.015
3.461

 

Sundry Debtors

3.455
2.182
2.180

 

Cash & Bank Balances

1.875
0.091
0.164

 

Other Current Assets

0.000
0.000
0.000

 

Loans & Advances and deposits

0.079
0.108
0.795

Total Current Assets

8.949
5.396
6.600

Less : CURRENT LIABILITIES & PROVISIONS

 
 
 

 

Sundry Creditors

2.215
1.284
1.628

 

Other Current Liabilities

0.127
0.165
0.127

 

Provisions

0.000
0.000
0.000

Total Current Liabilities

2.342
1.449
1.755

Net Current Assets

6.607
3.947
4.845

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

7.357

4.594

5.590

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

(PROVISIONAL)

31.03.2014

 

31.03.2013

 

SALES

 

 

 

 

 

Income

31.219

26.368

22.633

 

 

Other Income

2.135

3.436

4.060

 

 

TOTAL                                    

33.354

29.804

26.693

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Advertisement Expenses

0.018

0.815

0.050

 

 

Ambu.Int. Compo and Accessories

0.023

0.684

0.667

 

 

Ambu. Medi. Compo. and Accessories

1.582

0.421

0.353

 

 

Ambu. Labour Charges  for

0.421

0.000

0.000

 

 

Audit Fees

0.018

0.018

0.017

 

 

Bank Charges

0.009

0.036

0.053

 

 

Bank Interest

0.064

0.258

0.154

 

 

Bonus

0.031

0.033

0.006

 

 

Computer Expenses

0.009

0.003

0.007

 

 

Conveyance Expenses

0.021

0.050

0.035

 

 

Other Expenses

2.063

2.300

2.210

 

 

Cost of goods sold

27.292

24.291

22.365

 

 

Sales Return

1.267

0.513

0.458

 

 

TOTAL                                    

32.818

29.422

26.375

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

0.536

0.382

0.318

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

0.112

0.140

0.142

 

 

 

 

 

 

NET PROFIT

0.424

0.242

0.176

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

1.36

0.92

0.78

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

0.05

4.48

2.67

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.09

0.10

0.05

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.63

0.91

0.74

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

3.82

3.72

3.76

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

3.204

2.407

4.512

Reserves & Surplus

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

3.204

2.407

4.512

 

 

 

 

Secured loan

2.386

2.187

2.845

Unsecured loan

0.000

0.000

0.000

Current Maturities of Long Term Debt

0.000

0.000

0.000

Total borrowings

2.386

2.187

2.845

Debt/Equity ratio

0.745

0.909

0.631

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

22.633

26.368

31.219

 

 

16.502

18.397

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

22.633

26.368

31.219

Profit

0.176

0.242

0.424

 

0.78%

0.92%

1.36%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

Yes

5

Buyer visit details

Yes

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

No

10

Date of Birth of Proprietor / Partners / Directors

No

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

-----

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

-----

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

No

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

-----

33

Market information

-----

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

COMPUTATION OF TOTAL INCOME

Assessment Year: 2014-15

A/c Year Ending: 31.03.2014

 

INCOME FROM BUSINESS OR PROFESSION

Rs. In Million

Rs. In Million

Rs. In Million

Rs. In Million

Profit as per Profit and Loss A/c

 

0.242

 

 

Add: Disallowable/Addition:

 

 

 

 

Interest on Partner’s Capital

0.288

 

 

 

Salary to working partner

0.450

 

 

 

Depreciation

0.141

 

 

 

Any other item of addition under

0.004

0.883

 

 

Less: Business Deductions:

 

 

 

 

Current Depreciation U/s. 32(1)

 

 

 

 

Actual Depreciation (134571- -6180) c/f.

 

 

 

 

Depreciation adjust against current income

 

0.141

0.141

 

Interest on partner’s capital (12.00) u/s 40 (b) (v)

 

0.288

0.429

 

Book Profit

 

 

0.696

 

Remuneration/Salary to Working Partners u/s. 40 (b) (v)

 

0.450

0.450

 

Net Business Income

 

 

 

0.246

GROSS TOTAL INCOME

 

 

 

0.246

Total Income

 

 

 

0.246

Rounded off u/s. 288A

 

 

 

0.246

 

 

 

 

 

 

COMPUTATION OF TAX PAYABLE

 

Gross Tax on Rs. 0.246 (Normal)

0.074

Add: Surcharge Nil+ 2217 Edu. Cess and Higher Edu. Cess

0.002

 

0.076

 

Tax Calculation according to Section 115 JC of Income-tax Act (AMT)

 

TOTAL INCOME

 

0.242

 

ADJUSTED TOTAL INCOME

 

 

0.242

 

 

 

 

Tax on Above Income

 

0.045

 

Add: Surcharge 0+ 1346 Edu. Cess and Higher Edu. Cess

 

0.001

 

 

 

0.046

 

 

 

 

 

Gross Tax Payable (76116 or 46205 whichever is higher)

 

 

0.076

Tax Deducted at Source

 

 

 

Other than Salary

0.003

0.003

 

Total Prepaid Taxes

 

 

0.003

Tax Payable

 

 

0.073

Interest u/s. 234A for 6 Months

 

0.004

 

Interest u/s. 234B

 

0.008

 

Interest u/s. 234C :

 

 

 

Deferment of First Instalment

0.000

 

 

Deferment of Second Instalment

0.001

 

 

Deferment of Third Instalment

0.001

0.003

0.016

Balance Payable

 

 

0.089

Sales Assessment Tax Paid :

 

 

 

Scroll 00015/ 0201870 BSR Code 27.03.02015

 

0.089

0.089

BANK OF BARODA OLD PADRA ROAD

 

 

 

 

 

 

 

Net Tax Payable u/s/ 140A

 

 

3

Rounded off To Nearest 10

 

 

Nil

 

 

ALLOCATION BETWEEN PARTNERS:

 

Name of the Partners

(%)

Shares (Rs. In Million)

Int. on Capital

(Rs. In Million) Remuneration/ Salary

(%)

Diptiben Jaidip Trivedi

90.00

0.222

0.189

0.225

50.00

Jaidip Dineshbhai Trivedi

10.00

0.025

0.099

0.225

50.00

Total

100.00

0.246

0.283

0.450

100.00

 

 

 

 

 

 

 

PROJECTED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

5.261

4.964

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

0.000

0.000

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

5.261

4.964

LOAN FUNDS

 

 

 

1] Secured Loans

 

3.000

2.830

2] Unsecured Loans

 

0.000

0.000

TOTAL BORROWING

 

3.000

2.830

DEFERRED TAX LIABILITIES

 

0.000

0.000

 

 

 

 

TOTAL

 

8.261

7.794

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

0.530

0.623

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

0.015

0.015

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
4.285
3.895

 

Sundry Debtors

 
4.042
3.674

 

Cash & Bank Balances

 
1.920
1.880

 

Other Current Assets

 
0.000
0.000

 

Loans & Advances and deposits

 
0.077
0.077

Total Current Assets

 
10.324
9.526

Less : CURRENT LIABILITIES & PROVISIONS

 
 
 

 

Sundry Creditors

 
2.454
2.230

 

Other Current Liabilities

 
0.154
0.140

 

Provisions

 
0.000
0.000

Total Current Liabilities

 
2.608
2.370

Net Current Assets

 
7.716
7.156

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

8.261

7.794

 

 

PROJECTED PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

 

31.03.2016

 

SALES

 

 

 

 

 

Income

 

37.775

34.341

 

 

Other Income

 

2.584

2.350

 

 

TOTAL                                    

 

40.359

36.691

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Advertisement Expenses

 

0.022

0.019

 

 

Ambu.Int. Compo and Accessories

 

0.028

0.025

 

 

Ambu. Medi. Compo. and Accessories

 

1.914

0.463

 

 

Ambu. Labour Charges  for

 

0.509

1.740

 

 

Audit Fees

 

0.021

0.019

 

 

Bank Charges

 

0.012

0.011

 

 

Bank Interest

 

0.077

0.070

 

 

Bonus

 

0.037

0.034

 

 

Computer Expenses

 

0.011

0.011

 

 

Conveyance Expenses

 

0.026

0.024

 

 

Other Expenses

 

2.495

2.268

 

 

Cost of goods sold

 

32.692

29.720

 

 

Sales Return

 

1.534

1.396

 

 

TOTAL                                    

 

39.378

35.800

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

 

0.981

0.891

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

 

0.136

0.123

 

 

 

 

 

 

NET PROFIT

 

0.845

0.768

 

 

INTRODUCTION:

 

Yagna Medical Science was established in the year 2009 and spin off from well reputed YOGIRAJ MEDICAL ENGG. SYSTEM PRIVATE LIMITED AND VEEDY CORPORATION based at Baroda and Ahmedabad. The purpose of forming new firm is to provide world class Healthcare Solutions and Therepies for large nos of patients who are suffering from various aliment.

 

The core activity of YAGNA MEDICAL SCIENCE is in the fraternity of Nephrology, Urology, Critical Care, CNS, Virology, Emergency Medical Services and many more.

 

 

Their Business Association with following companies:

 

1. JOHNSON AND JOHNSON LIMITED

2. ROCHE SCIENTIFIC COMPANY LIMITED [Nephrology + Virology]

3. NOVARTIS INDIA LIMITED

4. BIOCON LIMITED [Nephrology + Transplant]

5. GENZYME

6. ABBOTT HEALTHCARE LIMITED

7. LA RENON HEALTHCARE [Nephroscience + Kirrus]

8. STEDFAST MEDISHIELD

9. GENNOVA BIOPHARMACUTICALS LIMITED

10. EMCURE PHARMACUTICALS LIMITED

11. CLARIS LIFESCEINCES LIMITED

 

 

NET WORTH CERTIFICATE

 

They hereby certify below the position of Assets and Liabilities of the person mentioned hereunder as on 31.03.2015

 

The same has been verified from the and other details produced before us:

 

 

Name: JAIDIP DINESHBHAI TRIVEDI

PAN: AAYPT6977F

Date of Birth: 06.09.1965

Permanent Address: 73, NAND RESIDENCY, OLD PADRA ROAD VADODARA-390020 INDIA

Office Address: 03, OMKAR KHARIVAV ROAD RAOPUR, VADODARA INDIA

 

(A) Total Value of Immovable Property:

 

(This includes beneficial share owned in Land, Building, Flat, Factory, Shop, House etc.)

 

Nature of Property

Location with Complete Address

Value at Cost (In Million)

RESIDENCE BUNGLOW at

73, NAND RESIDENCY, OLD PADRA ROAD, VADODARA – 390020, INDIA

11.100

(MKT. VALUE)

Shop

--

0

Shop

--

0

 

 

 

TOTAL

11.100

 

 

(B) Total Value of Other Assets

 

(This includes Cash, Bank Balance, Gold, Other Jewellery, Investment in Shares/Mutual Funds/FD’s/LIC etc, Vehicles, Capital in Business etc.)

 

Nature of Asset

Particulars of Asset/Complete Description

Qty.

Value at Cost (In Million)

LIC

LIC PREMIUM PAID APPX.

3

0.500

Jewellery

Jewellery APPX.

LOT

0.500

FDR and Bank

Bank BALANCE APPX.

1

0.100

Capital Investment

In Yagna Medical Science 31.03.2015 Provisional

1

1.343

TOTAL

 

2.443

 

 

(C) Total Liabilities

 

Borrowed From

Amount and Securities offered

Purpose

O/s as on date (Rs. In Million)

--

 

--

 

--

 

--

 

--

 

--

 

 

 

 

 

TOTAL

 

24.43

 

 

(D) Net Worth: (A+B-C) = /- 13.543 Million Approximately

 

He/ She is the Guarantor for various Borrowings by his/her friends / relatives / firms(s) / company(s) as detailed below.

 

 

Guaranteed to

For the Borrowings by

Purpose

Amount Guaranteed

(Rs. In Million)

BANK OF BARODA

YAGNA MEDICAL SCIENCE

Cash Credit

2.500

 

 

Vehicles

 

 

 

Cash Credit

 

 

 

 

 

TOTAL

 

2.500

 

 

Name: DIPTIBEN JAIDIP TRIVEDI

PAN: AHKPT8793L

Date of Birth: 30.11.1974

Permanent Address: 73, NAND RESIDENCY, OLD PADRA ROAD, VADODARA – 390020, INDIA

 

Office Address: 03, OMKAR KHARIV AV ROAD RAOPURA, VADODARA, INDIA

 

 

(A) Total Value of Immovable Property:

 

(This includes beneficial share owned in Land, Building, Flat, Factory, Shop, House etc.)

 

Nature of Property

Location with Complete Address

Value at Cost (Rs. In Millon)

RESIDENCE BUNGLOW at

---

----

Shop at

03, OMKAR, KHARIVAV ROAD, RAOPURA, VADODARA

3.000

(MKT. VALUE)

Shop

--

0

 

 

 

TOTAL

3.000

 

 

(B) Total Value of Other Assets:

 

(This includes Cash, Bank balance, Gold, Other Jewellery, Investment in Share/Mutual Funds/FD’s/LIC etc, Vehicles, Capital in Business etc.)

 

Nature of Asset

Particulars of Asset/Complete Description

Qty.

Value at Cost (In Million)

LIC

LIC PREMIUM PAID APPX.

3

0.500

Jewellery

Jewellery APPX.

LOT

0.500

FDR and Bank

Bank BALANCE APPX.

1

0.100

Capital Investment

In Yagna Medical Science 31.03.2015 Provisional

1

3.170

TOTAL

 

3.170

 

 

(C) Total Liabilities

 

Borrowed From

Amount and Securities offered

Purpose

O/s as on date (Rs. In Million)

--

 

--

 

--

 

--

 

--

 

--

 

 

 

 

 

TOTAL

 

0/-

 

 

(D) Net Worth: (A+B-C) = /-8.170 Million Approximately

 

He/ She is the Guarantor for various Borrowings by his/her friends/ relatives / firm(s) / company (s) as detailed below:

 

Guaranteed to

For the Borrowings by

Purpose

Amount Guaranteed

(Rs. In Million)

BANK OF BARODA

YAGNA MEDICAL SCIENCE

Cash Credit

2.500

 

 

Vehicles

 

 

 

Cash Credit

 

 

 

 

 

TOTAL

 

2.500

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction regstered against subject:                                                            None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 63.76

UK Pound

1

Rs. 97.80

Euro

1

Rs. 69.91

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

JYO

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.